| Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot | | |
| Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | | 2022 |
| Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study | | |
| Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer Using Optical Surface Management System – AlignRT as an Optical Body Surface Motion Management in Deep Breath Hold Patients: Results from a Single-Arm Retrospective Study | Cancer Management and Research | |
| Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next? | Current Treatment Options in Gastroenterology | |
| The Future Perspectives of Redefining the Resection Margin Status in Different Cancers of Pancreas | Open Access Macedonian Journal of Medical Sciences | 2022 |
| A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer | Internal Medicine | 2022 |
| Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer | JAMA Network Open | 2022 |
| Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysis | Journal of Surgical Oncology | |
| Proton Therapy in the Management of Pancreatic Cancer | Cancers | 2022 |
| Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review | Medicina (Lithuania) | 2022 |
| Prediction of Margin‐Negative Resection of Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy: Diagnostic Performance of NCCN Criteria for Resection vs. CT‐Determined Resectability | Journal of Hepato-Biliary-Pancreatic Sciences | |
| The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer | International Journal of Clinical Oncology | |
| The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways | Cancers | 2022 |
| Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study | Cancers | 2022 |
| PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies | Cancers | 2022 |
| Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer – an analysis of the Swedish national pancreatic cancer registry | Scandinavian Journal of Gastroenterology | |
| Distal Pancreatectomy with En Bloc Celiac Axis Resection | | 2022 |
| Pancreaticoduodenectomy with Splenic Artery Resection for Tumors of the Pancreatic Head and/or Body Invading the Splenic Artery | | 2022 |
| The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resection | Langenbeck's Archives of Surgery | |
| Real‐world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma | ANZ Journal of Surgery | |
| Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. | Annals of Surgical Oncology | 2022 |
| A multimodality review of solid and cystic pancreatic masses | | |
| Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium. | Annals of Surgical Oncology | 2022 |
| Response: Impact of Tumor Size on Outcomes for Patients with Resectable Distal Pancreatic Cancer. | Annals of Surgical Oncology | 2022 |
| Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis. | International Journal of Molecular Sciences | 2022 |
| Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma. | Therapeutic Advances in Medical Oncology | 2022 |
| Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? | Life | 2022 |
| Data_Sheet_1.docx | | 2019 |
| Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings. | European Journal of Radiology | 2022 |
| Prognosis following an extended duration of adjuvant gemcitabine plus S-1 chemotherapy in patients with pancreatic ductal adenocarcinoma: analysis using inverse probability of treatment weighting. | Journal of Hepato-Biliary-Pancreatic Sciences | 2022 |
| Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis. | Cancer Medicine | 2021 |
| The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. | Annals of Surgical Oncology | 2022 |
| Induction therapy with Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients. | European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
| ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer. | Annals of Surgical Oncology | 2022 |
| Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers. | Cancer | 2022 |
| Deciphering the Etiology of Weight Loss Following Pancreatectomy. | Annals of Surgical Oncology | 2022 |
| Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity. | Annals of Surgical Oncology | 2022 |
| Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications. | Cancers | 2022 |
| Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study. | Journal of Magnetic Resonance Imaging | 2022 |
| Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy. | Frontiers in Oncology | 2021 |
| Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. | International Journal of Molecular Sciences | 2022 |
| Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. | Journal of Gastrointestinal Surgery | 2022 |
| MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC). | Radiation Oncology | 2022 |
| A novel event-free survival endpoint in locally advanced pancreatic cancer | Therapeutic Advances in Medical Oncology | 2021 |
| A novel method for predicting perineural invasion of distal cholangiocarcinoma on multidetector-row computed tomography | Surgery Today | 2021 |
| An Evaluation of Total Internal Motions of Locally Advanced Pancreatic Cancer during SABR Using Calypso Extracranial Tracking, and Its Possible Clinical Impact on Motion Management. | Current Oncology | 2021 |
| Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma | Cancer Medicine | 2021 |
| Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience | Cureus | 2020 |
| Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy | Abdominal Imaging | 2006 |
